These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 9579536
1. Differential regulation of vitamin D responsive elements in normal and transformed keratinocytes. Xie Z, Bikle DD. J Invest Dermatol; 1998 May; 110(5):730-3. PubMed ID: 9579536 [Abstract] [Full Text] [Related]
4. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements. Staal A, Van Wijnen AJ, Desai RK, Pols HA, Birkenhäger JC, Deluca HF, Denhardt DT, Stein JL, Van Leeuwen JP, Stein GS, Lian JB. Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541 [Abstract] [Full Text] [Related]
5. All-trans retinoic acid blocks the antiproliferative prodifferentiating actions of 1,25-dihydroxyvitamin D3 in normal human keratinocytes. Gibson DF, Bikle DD, Harris J. J Cell Physiol; 1998 Jan; 174(1):1-8. PubMed ID: 9397150 [Abstract] [Full Text] [Related]
7. Cloning of the human phospholipase C-gamma1 promoter and identification of a DR6-type vitamin D-responsive element. Xie Z, Bikle DD. J Biol Chem; 1997 Mar 07; 272(10):6573-7. PubMed ID: 9045685 [Abstract] [Full Text] [Related]
8. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements. Verlinden L, Verstuyf A, Quack M, Van Camp M, Van Etten E, De Clercq P, Vandewalle M, Carlberg C, Bouillon R. J Bone Miner Res; 2001 Apr 07; 16(4):625-38. PubMed ID: 11315990 [Abstract] [Full Text] [Related]
9. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element. Imai Y, Pike JW, Koeffler HP. Leuk Res; 1995 Mar 07; 19(3):147-58. PubMed ID: 7700077 [Abstract] [Full Text] [Related]
10. Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene. MacDonald PN, Dowd DR, Nakajima S, Galligan MA, Reeder MC, Haussler CA, Ozato K, Haussler MR. Mol Cell Biol; 1993 Sep 07; 13(9):5907-17. PubMed ID: 8395017 [Abstract] [Full Text] [Related]
11. Squamous carcinoma cell lines fail to respond to 1,25-Dihydroxyvitamin D despite normal levels of the vitamin D receptor. Ratnam AV, Bikle DD, Su MJ, Pillai S. J Invest Dermatol; 1996 Mar 07; 106(3):522-5. PubMed ID: 8648187 [Abstract] [Full Text] [Related]
14. The retinoid X receptor agonist 9-cis-retinoic acid and the 24-hydroxylase inhibitor ketoconazole increase activity of 1,25-dihydroxyvitamin D3 in human skin in vivo. Kang S, Li XY, Duell EA, Voorhees JJ. J Invest Dermatol; 1997 Apr 07; 108(4):513-8. PubMed ID: 9077483 [Abstract] [Full Text] [Related]
15. Regulation of human placental lactogen expression by 1,25-dihydroxyvitamin D3. Stephanou A, Ross R, Handwerger S. Endocrinology; 1994 Dec 07; 135(6):2651-6. PubMed ID: 7988455 [Abstract] [Full Text] [Related]
17. Identification of 1 alpha,25-dihydroxyvitamin D3 response elements in the human transforming growth factor beta 2 gene. Wu Y, Craig TA, Lutz WH, Kumar R. Biochemistry; 1999 Mar 02; 38(9):2654-60. PubMed ID: 10052935 [Abstract] [Full Text] [Related]
18. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes. Ellison TI, Eckert RL, MacDonald PN. J Biol Chem; 2007 Apr 13; 282(15):10953-62. PubMed ID: 17310066 [Abstract] [Full Text] [Related]